Suchergebnisse | Systemseiten

Research Projects

ill patients. Improving Patient Outcome Plan (IPOP) Summary of Project Aims: This programme of work covers the development phase for a filovirus and an mpox Improving Patient Outcome Plan (IPOP). The programme

Research Projects

sequencing. Broad surveys of viruses in nature are technically challenging, especially when aiming to cover taxa abundance and diversity at sufficient depth and within a spatiotemporal structure. An effective

cell atlas for the full Trypanosoma cruzi life cycle based on >31,000 single-cell transcriptomes. Covers all life cycle stages, reveals surface antigen heterogeneity, differentiation dynamics and comprehensive

The Ongoing Evolution Of Variants Of Concern And Interest Of SARS-Cov-2 In Brazil Revealed by Convergent Indels in the Amino (N)-Terminal Domain of the Spike Protein

Resende PC, Naveca FG, Lins RD, Dezordi FZ, Ferraz MVF, Moreira EG, Coêlho DF, Motta FC, Paixão ACD, Appolinario L, Lopes RS, Mendonça ACDF, da Rocha ASB, Nascimento V, Souza V, Silva G, Nascimento F, Neto LGL, da Silva FV, Riediger I, Debur MDC, Leite AB, Mattos T, da Costa CF, Pereira FM, Dos Santos CA, Rovaris DB, Fernandes SB, Abbud A, Sacchi C, Khouri R, Bernardes AFL, Delatorre E, Gräf T, Siqueira MM, Bello G, Wallau GL
Virus Evolution. 2021 Aug 14;7(2):veab069. doi: 10.1093/ve/veab069
2021-01-01

Immunomodulatory Therapy in Children With Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-Cov-2 (PIMS-TS, MIS-C; RECOVERY): A Randomised, Controlled, Open-Label, Platform Trial

Faust SN, Haynes R, Jones CE, Staplin N, Whittaker E, Jaki T, Juszczak E, Spata E, Wan M, Bamford A, Dimitri P, Finn A, Furness J, Ramanan AV, Gale C, Cathie K, Drysdale S, Bernatoniene J, Murray C, ... Amuasi J, ... Zuriaga-Alvaro A.
The Lancet Child & Adolescent Health
2024-03-08

Efficacy of a Monovalent (D614) SARS-Cov-2 Recombinant Protein Vaccine with AS03 Adjuvant in Adults: A Phase 3, Multi-Country Study

Dayan GH, Rouphael N, Walsh SR, Chen A, Grunenberg N, Allen M, Antony J, Bhate AS, Beresnev T, Bonaparte MI, Celle M, Ceregido MA, Corey L, Fu B, Grillet MH, Keshtkar-Jahromi M, Juraska M, Kee JJ, Kaali S, Koutsoukos M, Masotti R, Michael NL, Neuzil KM, Reynales H, Robb ML, Uchiyama A, Sawe F, Schuerman L, Shrestha R, Tong T, Treanor J, Diazgranados CA, Chicz RM, Gurunathan S, Savarino S, Sridhar S; VAT00008 study team
EClinicalMedicine
2023-09-12

Efficacy of a Bivalent (D614 + B.1.351) SARS-Cov-2 Recombinant Protein Vaccine with AS03 Adjuvant in Adults: A Phase 3, Parallel, Randomised, Modified Double-Blind, Placebo-Controlled Trial

Dayan GH, Rouphael N, Walsh SR, Chen A, Grunenberg N, Allen M, Antony J, Asante KP, Bhate AS, Beresnev T, Bonaparte MI, Celle M, Ceregido MA, Corey L, Dobrianskyi D, Fu B, Grillet MH, Keshtkar-Jahromi M, Juraska M, Kee JJ, Kibuuka H, Koutsoukos M, Masotti R, Michael NL, Neuzil KM, Reynales H, Robb ML, Villagómez Martínez SM, Sawe F, Schuerman L, Tong T, Treanor J, Wartel TA, Diazgranados CA, Chicz RM, Gurunathan S, Savarino S, Sridhar S; VAT00008 Study Team
Lancet Respiratory Medicine
2023-11-01

Population-Based Cross-Sectional Seroprevalence Study of SARS-Cov-2 Infection in Urban Residential Areas in Ghana

Amuasi JH, Afum-Adjei Awuah A, Obirikorang C, Adu EA, Boham EEA, Boakye AO, Alani H, Newton S, Almoustapha NS, Deke J, Dzadey WO, Adu-Amoah L, Kroduah SA, Grant MA, Asare G, Amoako-Adusei A, Loag W, Kettenbeil J, Adu Sarkodie Y, Oduro E, Yawson AE, Apanga S, Odotei Adjei R, Adobasom Anane AG, Lorenz E, Souares A, Maiga Ascofare O, Jurgen M, Struck NS
BMJ Public Health
2025-06-23

Mutations in Ace2 Gene Modulate Cytokine Levels and Alter Immune Responses in Mycobacterium Tuberculosis and SARS-Cov-2 Co-Infection: A Cameroonian Cohort.

Kameni MN, Tchoupe EB, Kamdem SD, Bhalla N, Assam Assam JP, Tepa AN, Neba FR, Nanda RK, Awuah AA, Amuasi JH, Netongo PM
Frontiers in Immunology
2025-03-24

Kontakt

Bernhard-Nocht-Institut für Tropenmedizin

BNITM Presse

Filter